Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rochester, NY
NPI
1598109894
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
601 Elmwood Ave
Rochester, NY, 14642
Phone (585) 275-2901
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
254 services
Medicare patients, 2024
136
Average age 68
Drug cost, 2024
$373K
722 prescriptions
Company payments, 2023
$67.2
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Inga Harbuz-Miller was code 99214 (office e&m - established), 96 times for 76 patients. In total Inga Harbuz-Miller billed 254 services in 10 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 96 | 76 | $66.69 | $6,402 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 41 | 36 | $12.97 | $532 |
| 95251 Test - Miscellaneous | Facility | 25 | 18 | $27.31 | $683 |
| 99204 Office E&M - New | Facility | 25 | 25 | $101.55 | $2,539 |
| 99214 Office E&M - Established | Office | 24 | 19 | $82.35 | $1,976 |
By year: 2022 $17K for 225 services; 2023 $17K for 224 services; 2024 $16K for 254 services.
Medicare prescription drug claims, 2024
In 2024, the drug Inga Harbuz-Miller prescribed most often to Medicare patients was Levothyroxine Sodium, with 96 prescriptions and refills. In total Inga Harbuz-Miller wrote 722 Medicare prescriptions that cost $373K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 96 | 193 | 34 | $1,054 |
| Trulicity Dulaglutide | 56 | 80 | 19 | $73K |
| Ozempic Semaglutide | 44 | 51 | 16 | $48K |
| Methimazole Generic | 41 | 104 | 14 | $442 |
| Mounjaro Tirzepatide | 33 | 44 | Under 11 | $47K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 27 | 72 | 12 | $3,220 |
| Pioglitazone Hcl Generic | 26 | 38 | Under 11 | $75.21 |
| Jardiance Empagliflozin | 26 | 46 | Under 11 | $26K |
| Alendronate Sodium Generic | 25 | 70 | Under 11 | $214 |
| Hydrocortisone Generic | 21 | 49 | Under 11 | $792 |
| Metformin Hcl Generic | 18 | 48 | Under 11 | $75.59 |
| Januvia Sitagliptin Phosphate | 18 | 26 | Under 11 | $14K |
| Metformin Hcl Er Metformin Hcl | 18 | 54 | Under 11 | $310 |
| Lysodren Mitotane | 17 | 17 | Under 11 | $25K |
| Prednisone Generic | 16 | 38 | Under 11 | $112 |
Brand drugs: 367 claims; generic drugs: 313 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Inga Harbuz-Miller $67.2 ($67.2 in general payments such as food, travel and fees) from 1 company. The largest payer was Corcept Therapeutics with $67.2.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 1 | $67.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.